Computerized Checklist Offers Best Preventive Strategy For Deadly Blood Clots
10/17/2012
A computerized checklist system designed to help physicians identify and use the best methods of preventing potentially deadly blood clots in hospitalized trauma patients dramatically reduced the number of these dangerous venous thromboembolisms (VTEs), new Johns Hopkins research suggests...
Non-Small Cell Lung Cancer Patients 65 And Older Should Be Considered For Therapy
10/17/2012
Until there are more validated biomarkers to direct treatment decisions, many physicians use patient age to decide what therapy to give their patients. Literature data report that older patients often go undertreated because of concerns for limited tolerance to toxic therapies...
VeriStrat Predicts Response But Not Survival Benefit From Erlotinib
10/17/2012
A study, published in the November 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, showed the plasma test VeriStrat can predict response but not survival benefit from erlotinib. The study was conducted on a subset of patients enrolled in the NCIC Clinical Trials Group, BR...
How Expanding Waistlines May Contribute To Cancer
10/17/2012
Fat progenitor cells may contribute to cancer growth by fortifying the vessels that provide needed blood to tumors, according to preclinical research findings by investigators at The University of Texas Health Science Center at Houston (UTHealth). The results were reported in Cancer Research, a journal of the American Association for Cancer Research...
Mouse Model Shows Risk For Asthma, Allergies May Improve Fight Against Skin Cancer
10/17/2012
A molecule involved in asthma and allergies has now been shown to make mice resistant to skin cancer, according to scientists at Washington University School of Medicine in St. Louis. The molecule, called TSLP (thymic stromal lymphopoietin), is produced by damaged skin and activates the immune system...
Scientists Aiming For Lung Cancer Blood Test
10/17/2012
Early signs of lung cancer could be diagnosed using a simple blood test following a new discovery by scientists at the University of York. Early detection of lung cancer has been shown to save lives, but available methods for screening at-risk people are either too costly or involve invasive procedures...
Personalized Treatment Strategy, The Future For Childhood Cancer?
10/17/2012
After leukaemia and brain tumours, neuroblastoma is the most common form of cancer to affect children. A thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden, has studied a DNA method which is now used for all cases of neuroblastoma in Sweden, and which has led to more effective treatment at individual level...
New Radiation Treatment Significantly Increases Survival Rate
10/17/2012
A novel drug that mimics a naturally occurring molecule found in coffee and blueberries has been developed to treat radiation exposure. Charles R. Yates, Pharm.D., Ph.D., and colleagues Duane Miller, Ph.D., and Waleed Gaber, Ph.D...
New Insight Into The Progression And Invasiveness Of The Most Common Type Of Breast Cancer
10/17/2012
Ductal carcinoma in situ (DCIS) can be a predictor for invasive breast cancer if untreated, and is seen in around 45 percent of patients with invasive ductal carcinoma (IDC). Patients who only have DCIS, have a 5-year-survival of almost 100 percent on contrast to 89 percent of all stages of invasive breast cancer...
Computerized Checklist Offers Best Preventive Strategy For Deadly Blood Clots
10/17/2012
A computerized checklist system designed to help physicians identify and use the best methods of preventing potentially deadly blood clots in hospitalized trauma patients dramatically reduced the number of these dangerous venous thromboembolisms (VTEs), new Johns Hopkins research suggests...